Therefore, though reduced renal AMPK activity in metabolic diseases may contribute to salt and water imbalance in obesity- or diabetes-related disease, the role of AMPK in renal tubular handling in the metabolic disease associated kidney disease needs further investigation. This evidence concerns the gene PRKAA2 and metabolic disease.